Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA

NCT03172325 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Rheumatoid Arthritis

Interventions

DRUG: Adalimumab
DRUG: Methotrexate
DRUG: Folic Acid
DRUG: Prednisolone

Sponsor

Cinnagen